Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Regenerative Medicine Industry Outlook from 2023 to 2033

The regenerative medicine industry is estimated to be valued at US$ 13385.6 million in 2023. The industry is expected to reach US$ 73,084.2 million by 2033, developing at a CAGR of 18.5%.

Regenerative Medicine Industry Trend Analysis

  • The development of regenerative medicine products and investments in regenerative medicine research is increasing.
  • Precision medicine will expand as cancer biologics advance.
  • Advances in manufacturing technologies, such as 3D models of human disease, may make it possible to test the regenerative medicine approach in humans.
  • The growing investment in stem cell banking, cell manufacturing, and bioprocessing facilities supports the commercialization and accessibility of regenerative therapies.
Attributes Key Insights
Regenerative Medicine Industry Estimated Size in 2023 US$ 13,385.6 million
Projected Industry Value in 2033 US$ 73,084.2 million
Value-based CAGR from 2023 to 2033 18.5%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2017 to 2022 Historical Analysis vs. 2023 to 2033 Industry Forecast Projections

A study by our analysts found that a 16.2% CAGR was experienced between 2017 and 2022 in the regenerative medicine industry. Global demand for regenerative medicine is predicted to increase at a CAGR of 18.5% from 2023 to 2033.

The growth of the regenerative medicine industry is directly linked to the rising prevalence of chronic diseases along with the rise in wounds and injuries in the booming population. The prevalence of diseases in the increasing population is directly linked to the growth of the regenerative medicine industry.

Several regulatory laws provide technical guidance for regenerative medicine product quality. These therapy types substantially impact health and govern the approval of regenerative medicine products.

Increased biopharma funding has contributed to the growth of the regenerative medicine industry. Multinational corporations are beginning to develop long-term business models. Increase in pet adoption, veterinary professionals are becoming interested in regenerative medicine. The demand for allogeneic stem cell therapy has increased for its safe and effective effects on animals.

Historical CAGR from 2017 to 2022 16.2%
Forecast CAGR from 2023 to 2033 18.5%

Regenerative Medicine Industry Drivers

  • A large pool of the elderly population and the rising instances of external & internal injuries have led to increased uptake of regenerative medicines, driving market demand.
  • The rising incidence of chronic diseases such as cardiovascular diseases, diabetes, osteoarthritis, and autoimmune disorders has created a substantial demand for regenerative therapies
  • Increased patient awareness, coupled with patient demand for regenerative therapies, driving industry growth.
  • An increase in investment by private players and government organizations in the development of regenerative medicine, boosting the growth of the global industry during the forecast period.
  • The growing demand for customized and personalized medicines drives the market growth
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Regenerative Medicine Industry Restraints

  • Strict requirements for safety and efficacy by regulatory agencies can result in lengthy and costly approval processes.
  • The high costs of conducting clinical trials and ensuring the safety of new therapies may restrain demand.
  • The lack of advanced technical expertise and infrastructure availability makes it difficult for some regions or healthcare systems to adopt these treatments.
  • Securing funding for regenerative medicine research and development can be challenging.
  • There is a lack of reimbursement policies related to cell-based therapy
  • Restrictions in the adoption of regenerative medicine due to its intricate relation with immunology can restrict the regenerative medicine market.

Comparative View of Adjacent Markets

Regenerative Medicine Industry:

CAGR from 2023 to 2033 18.5%
Market Value in 2033 US$ 73,084.2 billion
Key Trends
  • Increased consumer awareness of regenerative medicine's potential benefits has led to a growing interest in these therapies
Opportunities
  • Increased demand for treatment of neurological disorders, including stroke and spinal cord injuries

Personalized Medicine Industry:

CAGR from 2023 to 2033 7.8%
Market Value in 2033 US$ 690.9 billion
Key Trends
  • The rising consumer awareness of the benefits of personalized treatment, and the development of more genetic databases.
Opportunities
  • The growing number of cancer types and the low cost of personalized medicine therapy in cancer medications

Nuclear Medicine Equipment Industry:

CAGR from 2023 to 2033 4.1%
Market Value in 2033 US$ 3.4 billion
Key Trends
  • The increasing frequency of cancer and cardiovascular illness and the growing need for image-guided operations and diagnostics.
Opportunities
  • Increased diagnostic nuclear medicine operations will assist in boosting nuclear medicine equipment demand in the approaching years.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-Wise Insights

Forecast CAGRs from 2023 to 2033

Australia 11.5%
China 27.2%
India 15.5%
The United Kingdom 13.2%

Growing Prevalence of Chronic Diseases to Drive Industry in China

The growing aging population, the adoption rate of regenerative medicines, and the prevalence of chronic diseases are contributing factors boosting the regenerative medicine industry in China. China is expected to account for a CAGR of 27.2% through 2033.

The government in China has been actively promoting the development of regenerative medicine through various initiatives and funding programs. Initiatives like the 'Made in China 2025' plan and the 'Healthy China 2030' plan prioritize the growth of biotechnology and healthcare industries, including regenerative medicine.

The demand for regenerative medicine will continue to increase in China in consideration of the above factors, promoting the value of the overall regenerative medicine Industry.

Rise of Regenerative Medicine in Australia Boosts the Industry Demand

The government in Australia has been actively supporting regenerative medicine research and development through various initiatives and grants. Australian scientists, biotech companies, and biomedical engineers have been at the forefront of advancements in regenerative medicine, propelling the industry's demand. Australia is expected to expand at a CAGR of 11.5% through 2033.

The presence of a high-quality healthcare system, experienced clinical research organizations (CROs), and a regulatory framework are expected to support the market growth. Australia has a well-defined regulatory framework for regenerative medicine products, providing a clear research, development, and commercialization pathway.

The Growing Government Support Influencing Industry Growth in India

India is one of the leading manufacturers of regenerative medicine. India is anticipated to rise at a CAGR of 15.5% during the forecast period due to the rising penetration of prominent manufacturers. Regenerative medicine therapies, such as stem cell-based treatments, are gaining popularity among medical tourists in the country.

The government in India has shown interest in promoting regenerative medicine and stem cell research. Initiatives such as the Department of Biotechnology's 'Stem Cell Research and Regenerative Medicine' program and the 'Make in India' campaign have provided support and incentives to the regenerative medicine industry.

United Kingdom Witness Increased Research and Development Investment in Regenerative Medicines

The growth of the regenerative medicine industry is attributed to extensive, cutting-edge research and development being carried out in the United Kingdom. The United Kingdom is expected to expand at a CAGR of 13.2% through 2033.

Large investment allocations by both government and private players are contributing to the growth of the industry in the United Kingdom. The presence of the biotechnology and pharmaceutical industry includes established companies and startups focused on regenerative medicine in the country.

Category-wise Insights

Category Expected Revenue Share in 2023
Tissue Engineering by Therapy 43%
Oncology by Application 30%

Growing Adoption of Tissue Engineering to Enhance the Industry Growth

Tissue engineering segment is expected to accumulate a market share of 43% in 2023. Tissue engineering is popular because of its adoption in tissue repair, thus accelerating Industry growth.

Tissue engineering in regenerative medicine finds applications in various medical fields, including orthopedics, cardiology, neurology, dermatology, and more. It is used for the regeneration of bone, cartilage, skin, blood vessels, and even complex organs like the heart and liver. Tissue engineering in the regenerative medicine market is highly regulated to ensure the safety and efficacy of products.

Oncology Application Spurs sales of Regenerative Medicine Globally

Oncology is expected to account for a value share of 40% as of 2023. The prevalence of cancer worldwide has driven this segment to be a dominant fragment, propelling sales of the overall regenerative medicine Industry.

Developing and testing regenerative medicine approaches in oncology are active areas of research and clinical trials. Regenerative medicines offer the potential to repair and regenerate these damaged tissues, improving the quality of life for cancer patients.

Competitive Landscape

With several competitors in regenerative medicine, the overall industry is fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as divestiture, partnerships and collaborations, and new therapy launches.

Some of the developments by players in the regenerative medicine industry are given below

  • In January 2022 - Stryker’s president joins the board of the regenerative medicine company Collagen Matrix, which will accelerate the growth strategy and further their vision of improving patient lives through innovative regenerative devices
  • In January 2021, Integra LifeSciences Holdings Corporation divestiture of its Extremity Orthopaedics business to Smith & Nephew, which will contribute to technologies in orthopedics and regenerative medicines.

Report Scope

Attributes Details
Estimated Industry Size in 2023 US$ 13385.6 million
Projected Industry Valuation in 2033 US$ 73084.2 million
Value-based CAGR 2023 to 2033 18.5%
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Industry Analysis Value in US$ billion
Key Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • Middle East and Africa
Key Industry Segments Covered
  • Therapy Type
  • Application
  • Region
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • The United Kingdom
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Czech Republic
  • Romania
  • India
  • Bangladesh
  • Australia
  • New Zealand
  • China
  • Japan
  • South Korea
  • GCC countries
  • South Africa
  • Israel
Key Companies Profiled
  • 3M
  • Allergan plc
  • Amgen, Inc.
  • Aspect Biosystems
  • bluebird bio
  • Kite Pharma
  • Integra LifeSciences Holdings Corporation
  • MEDIPOST Co., Ltd.
  • Anterogen Co., Ltd.
  • MiMedx Group
  • Misonix, Organogenesis Inc.
  • Orthocell Limited
  • Corestem, Inc.
  • Spark Therapeutics
  • APAC Biotech
  • Shenzhen Sibiono
  • GeneTech Co., Ltd.
  • Smith & Nephew plc
  • Stryker Corporation

Key Industry Segments Covered In Regenerative Medicine Industry Research

By Therapy type:

  • Cell Therapy
    • Autologous Cell Therapy
    • Allogenic Cell Therapy
  • Stem Cell Therapy
    • Allogeneic Stem Cell Therapy
    • Autologous Stem Cell Therapy
  • Tissue-engineering
  • Gene Therapy

By Application:

  • Wound Care
  • Musculoskeletal
  • Oncology
  • Dental
  • DMD (Duchenne Muscular Dystrophy)
  • Hepatological Diseases
  • Inflammatory & Autoimmune Diseases
  • Other Therapeutic Applications

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • Middle East and Africa

Frequently Asked Questions

What is the expected worth of the regenerative medicine industry in 2023?

The regenerative medicine industry is expected to reach US$ 13385.6 million in 2023.

What is the future of the regenerative medicine industry?

The market for regenerative medicine is set to expand by a CAGR of 18.5% by 2033.

How much valuation is projected for the regenerative medicine industry in 2033?

The regenerative medicine industry is forecast to reach US$ 73084.2 million by 2033.

Which region is likely to be leading in the regenerative medicine market?

A significant share of profits will likely come from the Industry in North America.

Which is the leading therapy type in the regenerative medicine domain?

The popularity of tissue engineering is expected to grow through 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Therapy Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Therapy Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Therapy Type, 2023 to 2033

        5.3.1. Cell Therapy

            5.3.1.1. Autologous Cell Therapy

            5.3.1.2. Allogenic Cell Therapy

        5.3.2. Stem Cell Therapy

            5.3.2.1. Allogeneic Stem Cell Therapy

            5.3.2.2. Autologous Stem Cell Therapy

        5.3.3. Tissue-engineering

        5.3.4. Gene Therapy

    5.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Therapy Type, 2023 to 2033

6. Global Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Wound Care

        6.3.2. Musculoskeletal

        6.3.3. Oncology

        6.3.4. Dental

        6.3.5. DMD (Duchenne Muscular Dystrophy)

        6.3.6. Hepatological Diseases

        6.3.7. Inflammatory & Autoimmune Diseases

        6.3.8. Other Therapeutic Applications

    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Therapy Type

        8.2.3. By Application

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Therapy Type

        8.3.3. By Application

    8.4. Key Takeaways

9. Latin America Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Therapy Type

        9.2.3. By Application

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Therapy Type

        9.3.3. By Application

    9.4. Key Takeaways

10. Western Europe Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Therapy Type

        10.2.3. By Application

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Therapy Type

        10.3.3. By Application

    10.4. Key Takeaways

11. Eastern Europe Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Therapy Type

        11.2.3. By Application

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Therapy Type

        11.3.3. By Application

    11.4. Key Takeaways

12. South Asia and Pacific Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Therapy Type

        12.2.3. By Application

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Therapy Type

        12.3.3. By Application

    12.4. Key Takeaways

13. East Asia Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Therapy Type

        13.2.3. By Application

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Therapy Type

        13.3.3. By Application

    13.4. Key Takeaways

14. Middle East and Africa Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Therapy Type

        14.2.3. By Application

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Therapy Type

        14.3.3. By Application

    14.4. Key Takeaways

15. Key Countries Industry Analysis and Outlook

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Therapy Type

            15.1.2.2. By Application

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Therapy Type

            15.2.2.2. By Application

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Therapy Type

            15.3.2.2. By Application

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Therapy Type

            15.4.2.2. By Application

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Therapy Type

            15.5.2.2. By Application

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Therapy Type

            15.6.2.2. By Application

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Therapy Type

            15.7.2.2. By Application

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Therapy Type

            15.8.2.2. By Application

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Therapy Type

            15.9.2.2. By Application

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Therapy Type

            15.10.2.2. By Application

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Therapy Type

            15.11.2.2. By Application

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Therapy Type

            15.12.2.2. By Application

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Therapy Type

            15.13.2.2. By Application

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Therapy Type

            15.14.2.2. By Application

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Therapy Type

            15.15.2.2. By Application

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Therapy Type

            15.16.2.2. By Application

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Therapy Type

            15.17.2.2. By Application

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Therapy Type

            15.18.2.2. By Application

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Therapy Type

            15.19.2.2. By Application

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Therapy Type

            15.20.2.2. By Application

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Therapy Type

            15.21.2.2. By Application

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Therapy Type

            15.22.2.2. By Application

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Therapy Type

            15.23.2.2. By Application

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Therapy Type

        16.3.3. By Application

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. 3M

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Allergan plc

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Amgen, Inc.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Aspect Biosystems

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. bluebird bio

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Kite Pharma

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Integra LifeSciences Holdings Corporation

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. MEDIPOST Co., Ltd.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Anterogen Co., Ltd.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. MiMedx Group

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

        17.1.11. Misonix, Organogenesis Inc.

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

        17.1.12. Orthocell Limited

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

        17.1.13. Corestem, Inc.

            17.1.13.1. Overview

            17.1.13.2. Product Portfolio

            17.1.13.3. Profitability by Market Segments

            17.1.13.4. Sales Footprint

            17.1.13.5. Strategy Overview

                17.1.13.5.1. Marketing Strategy

        17.1.14. Spark Therapeutics

            17.1.14.1. Overview

            17.1.14.2. Product Portfolio

            17.1.14.3. Profitability by Market Segments

            17.1.14.4. Sales Footprint

            17.1.14.5. Strategy Overview

                17.1.14.5.1. Marketing Strategy

        17.1.15. APAC Biotech

            17.1.15.1. Overview

            17.1.15.2. Product Portfolio

            17.1.15.3. Profitability by Market Segments

            17.1.15.4. Sales Footprint

            17.1.15.5. Strategy Overview

                17.1.15.5.1. Marketing Strategy

        17.1.16. Shenzhen Sibiono

            17.1.16.1. Overview

            17.1.16.2. Product Portfolio

            17.1.16.3. Profitability by Market Segments

            17.1.16.4. Sales Footprint

            17.1.16.5. Strategy Overview

                17.1.16.5.1. Marketing Strategy

        17.1.17. GeneTech Co., Ltd.

            17.1.17.1. Overview

            17.1.17.2. Product Portfolio

            17.1.17.3. Profitability by Market Segments

            17.1.17.4. Sales Footprint

            17.1.17.5. Strategy Overview

                17.1.17.5.1. Marketing Strategy

        17.1.18. Smith & Nephew plc

            17.1.18.1. Overview

            17.1.18.2. Product Portfolio

            17.1.18.3. Profitability by Market Segments

            17.1.18.4. Sales Footprint

            17.1.18.5. Strategy Overview

                17.1.18.5.1. Marketing Strategy

        17.1.19. Stryker Corporation

            17.1.19.1. Overview

            17.1.19.2. Product Portfolio

            17.1.19.3. Profitability by Market Segments

            17.1.19.4. Sales Footprint

            17.1.19.5. Strategy Overview

                17.1.19.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Industry Analysis and Outlook Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Industry Analysis and Outlook Value (US$ Million) Forecast by Therapy Type, 2018 to 2033

Table 3: Global Industry Analysis and Outlook Value (US$ Million) Forecast by Application, 2018 to 2033

Table 4: North America Industry Analysis and Outlook Value (US$ Million) Forecast by Country, 2018 to 2033

Table 5: North America Industry Analysis and Outlook Value (US$ Million) Forecast by Therapy Type, 2018 to 2033

Table 6: North America Industry Analysis and Outlook Value (US$ Million) Forecast by Application, 2018 to 2033

Table 7: Latin America Industry Analysis and Outlook Value (US$ Million) Forecast by Country, 2018 to 2033

Table 8: Latin America Industry Analysis and Outlook Value (US$ Million) Forecast by Therapy Type, 2018 to 2033

Table 9: Latin America Industry Analysis and Outlook Value (US$ Million) Forecast by Application, 2018 to 2033

Table 10: Western Europe Industry Analysis and Outlook Value (US$ Million) Forecast by Country, 2018 to 2033

Table 11: Western Europe Industry Analysis and Outlook Value (US$ Million) Forecast by Therapy Type, 2018 to 2033

Table 12: Western Europe Industry Analysis and Outlook Value (US$ Million) Forecast by Application, 2018 to 2033

Table 13: Eastern Europe Industry Analysis and Outlook Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Eastern Europe Industry Analysis and Outlook Value (US$ Million) Forecast by Therapy Type, 2018 to 2033

Table 15: Eastern Europe Industry Analysis and Outlook Value (US$ Million) Forecast by Application, 2018 to 2033

Table 16: South Asia and Pacific Industry Analysis and Outlook Value (US$ Million) Forecast by Country, 2018 to 2033

Table 17: South Asia and Pacific Industry Analysis and Outlook Value (US$ Million) Forecast by Therapy Type, 2018 to 2033

Table 18: South Asia and Pacific Industry Analysis and Outlook Value (US$ Million) Forecast by Application, 2018 to 2033

Table 19: East Asia Industry Analysis and Outlook Value (US$ Million) Forecast by Country, 2018 to 2033

Table 20: East Asia Industry Analysis and Outlook Value (US$ Million) Forecast by Therapy Type, 2018 to 2033

Table 21: East Asia Industry Analysis and Outlook Value (US$ Million) Forecast by Application, 2018 to 2033

Table 22: Middle East and Africa Industry Analysis and Outlook Value (US$ Million) Forecast by Country, 2018 to 2033

Table 23: Middle East and Africa Industry Analysis and Outlook Value (US$ Million) Forecast by Therapy Type, 2018 to 2033

Table 24: Middle East and Africa Industry Analysis and Outlook Value (US$ Million) Forecast by Application, 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Industry Analysis and Outlook Value (US$ Million) by Therapy Type, 2023 to 2033

Figure 2: Global Industry Analysis and Outlook Value (US$ Million) by Application, 2023 to 2033

Figure 3: Global Industry Analysis and Outlook Value (US$ Million) by Region, 2023 to 2033

Figure 4: Global Industry Analysis and Outlook Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 5: Global Industry Analysis and Outlook Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 6: Global Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 7: Global Industry Analysis and Outlook Value (US$ Million) Analysis by Therapy Type, 2018 to 2033

Figure 8: Global Industry Analysis and Outlook Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033

Figure 9: Global Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033

Figure 10: Global Industry Analysis and Outlook Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 11: Global Industry Analysis and Outlook Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 12: Global Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 13: Global Industry Analysis and Outlook Attractiveness by Therapy Type, 2023 to 2033

Figure 14: Global Industry Analysis and Outlook Attractiveness by Application, 2023 to 2033

Figure 15: Global Industry Analysis and Outlook Attractiveness by Region, 2023 to 2033

Figure 16: North America Industry Analysis and Outlook Value (US$ Million) by Therapy Type, 2023 to 2033

Figure 17: North America Industry Analysis and Outlook Value (US$ Million) by Application, 2023 to 2033

Figure 18: North America Industry Analysis and Outlook Value (US$ Million) by Country, 2023 to 2033

Figure 19: North America Industry Analysis and Outlook Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 20: North America Industry Analysis and Outlook Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 21: North America Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 22: North America Industry Analysis and Outlook Value (US$ Million) Analysis by Therapy Type, 2018 to 2033

Figure 23: North America Industry Analysis and Outlook Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033

Figure 24: North America Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033

Figure 25: North America Industry Analysis and Outlook Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 26: North America Industry Analysis and Outlook Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 27: North America Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 28: North America Industry Analysis and Outlook Attractiveness by Therapy Type, 2023 to 2033

Figure 29: North America Industry Analysis and Outlook Attractiveness by Application, 2023 to 2033

Figure 30: North America Industry Analysis and Outlook Attractiveness by Country, 2023 to 2033

Figure 31: Latin America Industry Analysis and Outlook Value (US$ Million) by Therapy Type, 2023 to 2033

Figure 32: Latin America Industry Analysis and Outlook Value (US$ Million) by Application, 2023 to 2033

Figure 33: Latin America Industry Analysis and Outlook Value (US$ Million) by Country, 2023 to 2033

Figure 34: Latin America Industry Analysis and Outlook Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 35: Latin America Industry Analysis and Outlook Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 36: Latin America Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 37: Latin America Industry Analysis and Outlook Value (US$ Million) Analysis by Therapy Type, 2018 to 2033

Figure 38: Latin America Industry Analysis and Outlook Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033

Figure 39: Latin America Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033

Figure 40: Latin America Industry Analysis and Outlook Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 41: Latin America Industry Analysis and Outlook Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 42: Latin America Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 43: Latin America Industry Analysis and Outlook Attractiveness by Therapy Type, 2023 to 2033

Figure 44: Latin America Industry Analysis and Outlook Attractiveness by Application, 2023 to 2033

Figure 45: Latin America Industry Analysis and Outlook Attractiveness by Country, 2023 to 2033

Figure 46: Western Europe Industry Analysis and Outlook Value (US$ Million) by Therapy Type, 2023 to 2033

Figure 47: Western Europe Industry Analysis and Outlook Value (US$ Million) by Application, 2023 to 2033

Figure 48: Western Europe Industry Analysis and Outlook Value (US$ Million) by Country, 2023 to 2033

Figure 49: Western Europe Industry Analysis and Outlook Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 50: Western Europe Industry Analysis and Outlook Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 51: Western Europe Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 52: Western Europe Industry Analysis and Outlook Value (US$ Million) Analysis by Therapy Type, 2018 to 2033

Figure 53: Western Europe Industry Analysis and Outlook Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033

Figure 54: Western Europe Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033

Figure 55: Western Europe Industry Analysis and Outlook Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 56: Western Europe Industry Analysis and Outlook Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 57: Western Europe Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 58: Western Europe Industry Analysis and Outlook Attractiveness by Therapy Type, 2023 to 2033

Figure 59: Western Europe Industry Analysis and Outlook Attractiveness by Application, 2023 to 2033

Figure 60: Western Europe Industry Analysis and Outlook Attractiveness by Country, 2023 to 2033

Figure 61: Eastern Europe Industry Analysis and Outlook Value (US$ Million) by Therapy Type, 2023 to 2033

Figure 62: Eastern Europe Industry Analysis and Outlook Value (US$ Million) by Application, 2023 to 2033

Figure 63: Eastern Europe Industry Analysis and Outlook Value (US$ Million) by Country, 2023 to 2033

Figure 64: Eastern Europe Industry Analysis and Outlook Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 65: Eastern Europe Industry Analysis and Outlook Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 66: Eastern Europe Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 67: Eastern Europe Industry Analysis and Outlook Value (US$ Million) Analysis by Therapy Type, 2018 to 2033

Figure 68: Eastern Europe Industry Analysis and Outlook Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033

Figure 69: Eastern Europe Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033

Figure 70: Eastern Europe Industry Analysis and Outlook Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 71: Eastern Europe Industry Analysis and Outlook Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 72: Eastern Europe Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 73: Eastern Europe Industry Analysis and Outlook Attractiveness by Therapy Type, 2023 to 2033

Figure 74: Eastern Europe Industry Analysis and Outlook Attractiveness by Application, 2023 to 2033

Figure 75: Eastern Europe Industry Analysis and Outlook Attractiveness by Country, 2023 to 2033

Figure 76: South Asia and Pacific Industry Analysis and Outlook Value (US$ Million) by Therapy Type, 2023 to 2033

Figure 77: South Asia and Pacific Industry Analysis and Outlook Value (US$ Million) by Application, 2023 to 2033

Figure 78: South Asia and Pacific Industry Analysis and Outlook Value (US$ Million) by Country, 2023 to 2033

Figure 79: South Asia and Pacific Industry Analysis and Outlook Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 80: South Asia and Pacific Industry Analysis and Outlook Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 81: South Asia and Pacific Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 82: South Asia and Pacific Industry Analysis and Outlook Value (US$ Million) Analysis by Therapy Type, 2018 to 2033

Figure 83: South Asia and Pacific Industry Analysis and Outlook Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033

Figure 84: South Asia and Pacific Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033

Figure 85: South Asia and Pacific Industry Analysis and Outlook Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 86: South Asia and Pacific Industry Analysis and Outlook Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 87: South Asia and Pacific Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 88: South Asia and Pacific Industry Analysis and Outlook Attractiveness by Therapy Type, 2023 to 2033

Figure 89: South Asia and Pacific Industry Analysis and Outlook Attractiveness by Application, 2023 to 2033

Figure 90: South Asia and Pacific Industry Analysis and Outlook Attractiveness by Country, 2023 to 2033

Figure 91: East Asia Industry Analysis and Outlook Value (US$ Million) by Therapy Type, 2023 to 2033

Figure 92: East Asia Industry Analysis and Outlook Value (US$ Million) by Application, 2023 to 2033

Figure 93: East Asia Industry Analysis and Outlook Value (US$ Million) by Country, 2023 to 2033

Figure 94: East Asia Industry Analysis and Outlook Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 95: East Asia Industry Analysis and Outlook Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 96: East Asia Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 97: East Asia Industry Analysis and Outlook Value (US$ Million) Analysis by Therapy Type, 2018 to 2033

Figure 98: East Asia Industry Analysis and Outlook Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033

Figure 99: East Asia Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033

Figure 100: East Asia Industry Analysis and Outlook Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 101: East Asia Industry Analysis and Outlook Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 102: East Asia Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 103: East Asia Industry Analysis and Outlook Attractiveness by Therapy Type, 2023 to 2033

Figure 104: East Asia Industry Analysis and Outlook Attractiveness by Application, 2023 to 2033

Figure 105: East Asia Industry Analysis and Outlook Attractiveness by Country, 2023 to 2033

Figure 106: Middle East and Africa Industry Analysis and Outlook Value (US$ Million) by Therapy Type, 2023 to 2033

Figure 107: Middle East and Africa Industry Analysis and Outlook Value (US$ Million) by Application, 2023 to 2033

Figure 108: Middle East and Africa Industry Analysis and Outlook Value (US$ Million) by Country, 2023 to 2033

Figure 109: Middle East and Africa Industry Analysis and Outlook Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 110: Middle East and Africa Industry Analysis and Outlook Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 111: Middle East and Africa Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 112: Middle East and Africa Industry Analysis and Outlook Value (US$ Million) Analysis by Therapy Type, 2018 to 2033

Figure 113: Middle East and Africa Industry Analysis and Outlook Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033

Figure 114: Middle East and Africa Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033

Figure 115: Middle East and Africa Industry Analysis and Outlook Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 116: Middle East and Africa Industry Analysis and Outlook Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 117: Middle East and Africa Industry Analysis and Outlook Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 118: Middle East and Africa Industry Analysis and Outlook Attractiveness by Therapy Type, 2023 to 2033

Figure 119: Middle East and Africa Industry Analysis and Outlook Attractiveness by Application, 2023 to 2033

Figure 120: Middle East and Africa Industry Analysis and Outlook Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Personalized Medicine Market

Published : January 2023

Healthcare

Regenerative Artificial Skin Market

Published : October 2022

Healthcare

Nuclear Medicine Equipment Market

Published : October 2022

Explore Healthcare Insights

View Reports

Regenerative Medicine Market